Clinical Trial Update: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) [Phase 1, Phase 2]

View source ↗

Summary

Georgetown University's Phase 1/2 trial of CyberKnife stereotactic accelerated partial breast irradiation (SAPBI) for breast cancer and ductal carcinoma in situ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Invasive Ductal Carcinoma

Snippet

Sponsor: Georgetown University | Conditions: Breast Cancer, DCIS | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-04-13